000 01347 a2200373 4500
005 20250515131413.0
264 0 _c20090122
008 200901s 0 0 eng d
022 _a0741-238X
024 7 _a10.1007/s12325-008-0078-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKahook, Malik Y
245 0 0 _aQuantitative analysis of conjunctival goblet cells after chronic application of topical drops.
_h[electronic resource]
260 _bAdvances in therapy
_cAug 2008
300 _a743-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBenzalkonium Compounds
_xpharmacology
650 0 4 _aCell Count
650 0 4 _aCloprostenol
_xanalogs & derivatives
650 0 4 _aConjunctiva
_xcytology
650 0 4 _aGoblet Cells
_xcytology
650 0 4 _aLatanoprost
650 0 4 _aMale
650 0 4 _aOphthalmic Solutions
_xpharmacology
650 0 4 _aPreservatives, Pharmaceutical
_xpharmacology
650 0 4 _aProstaglandins F, Synthetic
_xpharmacology
650 0 4 _aRabbits
650 0 4 _aTravoprost
700 1 _aNoecker, Robert
773 0 _tAdvances in therapy
_gvol. 25
_gno. 8
_gp. 743-51
856 4 0 _uhttps://doi.org/10.1007/s12325-008-0078-y
_zAvailable from publisher's website
999 _c18147091
_d18147091